NK:IO
PrivateLast Round
Seed
Oct 23, 2024
Total Funding Raised
$7.4M
Company Overview
NK:IO is a biotechnology company developing off-the-shelf natural killer (NK) cell therapies for the treatment of solid tumours.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NK:IO Comparables
Compare NK:IO with similar companies based on industry and business-model similarity.
NK:IO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 23, 2024 |
NK:IO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start Codon | Seed |
| Cambridge Angels | Seed |
| Meltwind Advisory | Seed |
| UK Innovation & Science Seed Fund | Seed |
| Cancer Research Horizons | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 220% MoM, reaching 3.1K.
- May 3, 2025
Monthly visitors increased 133% MoM, reaching 2.3K.
NK:IO Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NK:IO's valuation, stock price, and market status.